Prevalence of clinically meaningful antiphospholipid antibodies in patients with systemic lupus erythematosus varies by race and ethnicity

Authors:

Abstract
No abstract available
Funding Information
  • UCB
  • Centers for Disease Control and Prevention (U01 DP005120, U01 DP006701)
  • National Center for Advancing Translational Sciences of the National Institutes of Health (UL1 TR001450)
  • National Institutes of Health (K24 AR068406, P30 AR072582, RO1 AR49772)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases